Gene Technology a Revolution in Cancer Fight

November 6, 2013

An article in the Pittsburgh Tribune-Review details how advances in DNA sequencing have been able to uncover genetic alterations that are linked to cancers, and therefore, potentially inform care. But, some gene alterations, which can arise spontaneously during a person's life, might be meaningless in helping some patients. David Roth, MD, PhD, chair of Pathology and Laboratory Medicine and director of the Center for Personalized Diagnostics with the Department and the Abramson Cancer Center, commented “No matter what kind of cancer you have, you want to get information like this so that you can potentially benefit if you're one of the people that have one of those mutations.”

Read the entire Pittsburgh Tribune-Review article